S&P TSX Capped Composite...

US Dollar vs CAD

Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Get Started

MTNB Matinas Biopharma Holdings Inc

0.579

0.003 (0.52%)

Pre Market

Last Updated: 07:44:38

Delayed by 15 minutes

Form 3 - Initial statement of beneficial ownership of securities

Matinas Biopharma (AMEX:MTNB)
Historical Stock Chart
From Jan 2025 to Feb 2025

Click Here for more Matinas Biopharma Charts.

Matinas Biopharma (AMEX:MTNB)
Historical Stock Chart
From Feb 2024 to Feb 2025

Click Here for more Matinas Biopharma Charts.

Matinas Biopharma Holdings Inc News

Form 3 - Initial statement of beneficial ownership of securities
Tuesday 25 February 2025 (2 days ago) • Edgar (US Regulatory)

Form PRE 14A - Other preliminary proxy statements
Friday 21 February 2025 (6 days ago) • Edgar (US Regulatory)

Form SCHEDULE 13D - General Statement of Acquisition of Beneficial Ownership
Friday 21 February 2025 (6 days ago) • Edgar (US Regulatory)

Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
Wednesday 19 February 2025 (1 week ago) • Edgar (US Regulatory)

Form 8-K - Current report
Thursday 13 February 2025 (2 weeks ago) • Edgar (US Regulatory)

Matinas BioPharma Announces Agreement for the Acquisition of Preferred Stock and Appointment of Dr. Robin L. Smith to the Board of Directors
Thursday 13 February 2025 (2 weeks ago) • GlobeNewswire Inc.

Form 8-K - Current report
Tuesday 11 February 2025 (2 weeks ago) • Edgar (US Regulatory)

Form 8-K - Current report
Friday 7 February 2025 (3 weeks ago) • Edgar (US Regulatory)

Matinas BioPharma Appoints Evelyn D’An to Board of Directors as Audit Committee Chair
Friday 7 February 2025 (3 weeks ago) • GlobeNewswire Inc.

Form 8-K - Current report
Friday 24 January 2025 (1 month ago) • Edgar (US Regulatory)

Form 8-K - Current report
Friday 10 January 2025 (2 months ago) • Edgar (US Regulatory)

Matinas BioPharma Receives NYSE Noncompliance Notice
Friday 10 January 2025 (2 months ago) • GlobeNewswire Inc.

More Matinas Biopharma Holdings Inc News Articles

WisdomTree Metal Securit...

Amundi MSCI China A UCIT...

iShares JP Morgan EM Loc...

EKF Diagnostics

Exchange Traded

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions